ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,180.74
1.03%
Dow Jones
38,852.27
0.46%
US Dollar vs MXN
16.87701
-0.05%
Brent Oil
83.335
-0.17%
Bitcoin
63,789.20
0.99%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. NexGel Inc (NXGL)

  7. NexGel Inc (NXGL) Noticias

NXGL NexGel Inc

2.20
-0.02 (-0.90%)
06 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
NexGel Inc NXGL NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.02 -0.90% 2.20 16:16:11
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.13 2.13 2.22 2.20 2.22
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
06/5/202415:05GLOBENEXGEL to Present at the Aegis Capital Virtual Conference on..
18/4/202407:00GLOBENEXGEL to Present at the Planet MicroCap Showcase: VEGAS..
01/4/202406:50GLOBENEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an..
27/3/202408:00GLOBENEXGEL Reschedules Fourth Quarter and Full Year 2023..
21/3/202408:00GLOBENEXGEL to Report Fourth Quarter and Full Year 2023 Financial..
05/3/202408:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202408:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202407:30GLOBENEXGEL to Present at the iAccess Alpha Best Ideas Spring..
21/2/202415:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
21/2/202415:15EDGAR2Form 8-K - Current report
21/2/202415:05GLOBENEXGEL Announces $975,000 Registered Direct Offering Led by..
31/1/202408:05EDGAR2Form 8-K - Current report
18/1/202408:00GLOBENEXGEL to Present at The Microcap Conference, January 30th..
16/1/202415:30EDGAR2Form 8-K - Current report
09/1/202407:30GLOBENEXGEL Subsidiary, CG Converting and Packaging, Begins..
29/12/202315:30EDGAR2Form 8-K - Current report
26/12/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202315:52EDGAR2Form 8-K - Current report
11/12/202307:15EDGAR2Form 8-K - Current report
11/12/202307:00GLOBENEXGEL Announces Partnership with STADA to Distribute and..
05/12/202307:10EDGAR2Form 8-K - Current report
05/12/202307:00GLOBENEXGEL Acquires Kenkoderm Psoriasis Skincare Line
13/11/202316:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202316:10EDGAR2Form 8-K - Current report
13/11/202315:05GLOBENEXGEL Reports Record Third Quarter 2023 Revenue of $1.2..
02/11/202308:00GLOBENEXGEL to Report Third Quarter 2023 Financial Results on..
30/10/202307:30EDGAR2Form 8-K - Current report
30/10/202307:00GLOBENEXGEL Secures Supply Agreement with AbbVie
26/9/202308:49GLOBENEXGEL to Participate in the LD Micro Main Event XVI on..
14/9/202317:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202317:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202315:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202315:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202315:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202316:29EDGAR2Form 8-K - Current report
14/8/202315:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202315:05GLOBENEXGEL Reports Second Quarter 2023 Record Revenue of $1.17..
02/8/202308:00GLOBENEXGEL to Report Second Quarter 2023 Financial Results on..
19/7/202308:10GLOBENEXGEL Partners with Enigma Health to Distribute its Leading..
15/6/202308:00GLOBENEXGEL to Participate in Maxim Group’s Virtual Healthcare..
24/5/202308:00GLOBENEXGEL to Participate in the LD Micro Invitational XIII on..
15/5/202315:05GLOBENEXGEL Reports First Quarter 2023 Financial Results
09/5/202308:15GLOBENEXGEL to Report First Quarter 2023 Financial Results on May..

Su Consulta Reciente

NASDAQ
NXGL
NexGel
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados